BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6127382)

  • 21. Increased sensitivity of platelets to adrenaline in human myotonic dystrophy.
    Bousser MG; Conard J; Lecrubier C; Samama M
    Lancet; 1975 Aug; 2(7929):307-9. PubMed ID: 50512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
    Kornecki E; Ehrlich YH; Lenox RH
    Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of fenflumizole on platelet aggregation in man.
    Grande P; Wadt J; Corell T
    Eur J Clin Pharmacol; 1984; 27(2):169-72. PubMed ID: 6437841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects.
    David JL; Monfort F; Herion F; Raskinet R
    Thromb Res; 1979 Jan; 14(1):35-49. PubMed ID: 425084
    [No Abstract]   [Full Text] [Related]  

  • 25. [Action of ethacrynic acid on vitro in platelet aggregation induced by ADP, adrenaline or collagen].
    Vittoria A; Laghi Pasini F; De Gori V; Forconi S; Di Perri T
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1397-42. PubMed ID: 4458729
    [No Abstract]   [Full Text] [Related]  

  • 26. Qualitative platelet defect in a case of heparin-induced thrombocytopenia.
    Chong BH; Grace CS; Rozenberg MC; Castaldi PA
    Scand J Haematol; 1983 May; 30(5):427-9. PubMed ID: 6407097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action in vitro of isoxsurprine on platelet aggregation induced by ADP, adrenaline and collagen].
    Di Perri T; Forconi S; Vittoria A; Laghi Pasini F; De Gori V
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1385-90. PubMed ID: 4458727
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of the equine platelet aggregation response.
    Meyers KM; Lindner C; Grant B
    Am J Vet Res; 1979 Feb; 40(2):260-4. PubMed ID: 464363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of three nonsteroidal anti-inflammatory agents on platelet function and prostaglandin synthesis in vitro.
    McIntyre BA; Philp RB
    Thromb Res; 1978 Jan; 12(1):67-77. PubMed ID: 644561
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E
    Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovine platelet function and its inhibition by T-2 toxin.
    Gentry PA; Socha AS; Ross ML
    Vet Res Commun; 1987; 11(5):457-66. PubMed ID: 3127991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action of furosemide on vitro in platelet aggregation by ADP, adrenaline or collagen].
    Vittoria A; Laghi Pasini F; De Gori V; Forconi S; Di Perri T
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1391-6. PubMed ID: 4458728
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
    Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atrial natriuretic factor on human platelet function.
    De Caterina R; Volpe M; Atlas SA; Weksler BB
    Life Sci; 1985 Oct; 37(15):1395-402. PubMed ID: 2931566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 6-[p-(4-phenylacetylpiperazin-1-yl)phenyl]-4,5-dihydro-3(2H)pyridazinone (CCI 17810) and aspirin on platelet aggregation and adhesiveness.
    Griffett EM; Kinnon SM; Kumar A; Lecker D; Smith GM; Tomich EG
    Br J Pharmacol; 1981 Apr; 72(4):697-705. PubMed ID: 7284687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 40. Hirudin and platelets.
    Glusa E
    Semin Thromb Hemost; 1991 Apr; 17(2):122-5. PubMed ID: 1771409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.